📰 Libra Wealth News
Page 5 - Libra Wealth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Libra Wealth. Real-time updates on events, politics, business and more.
April 12, 2023
Libra Wealth LLC increased its holdings in shares of Avantis International Small Cap Value ETF (NYSEARCA:AVDV – Get Rating) by 2.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 30,959 shares of the company’s stock after buying an additional 667 […]
April 12, 2023
Autumn Glory Partners LLC boosted its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 146.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,753 shares of the company’s stock after acquiring an additional 18,843 shares during the quarter. AbbVie […]
April 12, 2023
Libra Wealth LLC grew its position in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA – Get Rating) by 9.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 274,899 shares of the company’s stock after acquiring an additional 23,152 shares during the […]
April 12, 2023
Libra Wealth LLC increased its position in Dimensional U.S. Targeted Value ETF (NYSEARCA:DFAT – Get Rating) by 6.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 344,294 shares of the company’s stock after acquiring an additional 20,788 shares during the quarter. Dimensional U.S. Targeted […]
April 12, 2023
Should You Buy or Sell Invesco QQQ Stock? Get The Latest QQQ Stock Price, Constituents List, Holdings Data, Headlines, Short Interest at MarketBeat.
April 9, 2023
PFG Advisors increased its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 31.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,607 shares of the company’s stock after buying an additional 5,824 shares during the period. PFG […]
April 8, 2023
Motive Wealth Advisors raised its stake in AbbVie Inc. (NYSE:ABBV – Get Rating) by 38.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,098 shares of the company’s stock after buying an additional 586 shares during the period. Motive Wealth Advisors’ holdings in AbbVie […]
April 7, 2023
Arbor Investment Advisors LLC lifted its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 30.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,986 shares of the company’s stock after buying an additional 698 shares during the quarter. Arbor Investment Advisors […]
April 6, 2023
Humankind Investments LLC trimmed its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 8.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 13,898 shares of the company’s stock after selling 1,321 shares during the quarter. AbbVie makes up approximately 1.0% of Humankind Investments LLC’s portfolio, making the stock its 16th biggest position. […]
April 5, 2023
SevenBridge Financial Group LLC boosted its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 0.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 19,578 shares of the company’s stock after acquiring an additional 155 shares during the period. SevenBridge Financial Group […]